長期投資家のためのIR情報
バリュートレンド

【8129】東邦ホールディングス
医薬品の卸売。調剤薬局も。

売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)
対前回 修正率 修正率 営業利益
(百万円)
対前回 修正率 修正率 経常利益
(百万円)
対前回 修正率 修正率 当期利益
(百万円)
対前回 修正率 修正率
2027.03 2026/08/05 Q1予 1,601,000 → 0.0% 0.0% 14,800 → 0.0% 0.0% 16,600 → 0.0% 0.0% 12,900 → 0.0% 0.0%
2027.03 2026/05/13 当初予 1,601,000 - - - 14,800 - - - 16,600 - - - 12,900 - - -
2026.03 2026/05/13 実 1,553,364 ↑ +0.0% -1.2% 16,601 ↑ +0.6% -19.8% 16,631 ↑ +0.2% -26.4% 17,327 ↑ +0.2% +10.4%
2026.03 2026/04/28 修正予 1,553,000 ↓ -1.2% -1.2% 16,500 ↓ -20.3% -20.3% 16,600 ↓ -26.5% -26.5% 17,300 ↑ +10.2% +10.2%
2026.03 2026/02/12 Q3予 1,572,000 → 0.0% 0.0% 20,700 → 0.0% 0.0% 22,600 → 0.0% 0.0% 15,700 → 0.0% 0.0%
2026.03 2025/11/12 Q2予 1,572,000 → 0.0% 0.0% 20,700 → 0.0% 0.0% 22,600 → 0.0% 0.0% 15,700 → 0.0% 0.0%
2026.03 2025/08/05 Q1予 1,572,000 → 0.0% 0.0% 20,700 → 0.0% 0.0% 22,600 → 0.0% 0.0% 15,700 → 0.0% 0.0%
2026.03 2025/05/14 当初予 1,572,000 - - - 20,700 - - - 22,600 - - - 15,700 - - -
2025.03 2025/05/14 実 1,518,495 ↑ +1.8% +1.8% 18,936 ↑ +4.0% +4.0% 20,716 ↑ +3.1% +3.1% 19,844 ↑ +17.4% +58.8%
2025.03 2025/02/07 Q3予 1,492,000 → 0.0% 0.0% 18,200 → 0.0% 0.0% 20,100 → 0.0% 0.0% 16,900 → 0.0% +35.2%
2025.03 2025/01/15 修正予 1,492,000 → 0.0% 0.0% 18,200 → 0.0% 0.0% 20,100 → 0.0% 0.0% 16,900 ↑ +35.2% +35.2%
2025.03 2024/11/08 Q2予 1,492,000 → 0.0% 0.0% 18,200 → 0.0% 0.0% 20,100 → 0.0% 0.0% 12,500 → 0.0% 0.0%
2025.03 2024/08/06 Q1予 1,492,000 → 0.0% 0.0% 18,200 → 0.0% 0.0% 20,100 → 0.0% 0.0% 12,500 → 0.0% 0.0%
2025.03 2024/05/10 当初予 1,492,000 - - - 18,200 - - - 20,100 - - - 12,500 - - -
2024.03 2024/05/10 実 1,476,712 ↑ +0.0% +11.4% 19,331 ↑ +0.2% +68.1% 21,787 ↑ +0.4% +57.9% 20,657 ↑ +0.3% +67.9%
2024.03 2024/04/30 修正予 1,476,000 ↑ +1.2% +11.4% 19,300 ↑ +53.2% +67.8% 21,700 ↑ +40.0% +57.2% 20,600 ↑ +42.1% +67.5%
2024.03 2024/02/08 Q3予 1,458,000 ↑ +10.0% +10.0% 12,600 ↑ +9.6% +9.6% 15,500 ↑ +12.3% +12.3% 14,500 ↑ +17.9% +17.9%
2024.03 2023/11/10 Q2予 1,325,000 → 0.0% 0.0% 11,500 → 0.0% 0.0% 13,800 → 0.0% 0.0% 12,300 → 0.0% 0.0%
2024.03 2023/08/04 Q1予 1,325,000 - - - 11,500 - - - 13,800 - - - 12,300 - - -
2023.03 2023/02/09 Q3予 1,269,000 → 0.0% 0.0% 12,300 → 0.0% 0.0% 17,600 → 0.0% 0.0% 11,300 → 0.0% 0.0%
2023.03 2022/11/11 Q2予 1,269,000 → 0.0% 0.0% 12,300 → 0.0% 0.0% 17,600 → 0.0% 0.0% 11,300 → 0.0% 0.0%
2023.03 2022/08/05 Q1予 1,269,000 - - - 12,300 - - - 17,600 - - - 11,300 - - -
2022.03 2022/04/18 修正予 1,265,000 ↑ +6.1% +6.1% 12,100 ↑ +89.1% +89.1% 17,700 ↑ +48.7% +48.7% 12,800 ↑ +73.0% +73.0%
2022.03 2022/02/09 Q3予 1,192,000 → 0.0% 0.0% 6,400 → 0.0% 0.0% 11,900 → 0.0% 0.0% 7,400 → 0.0% 0.0%
2022.03 2021/11/12 Q2予 1,192,000 → 0.0% 0.0% 6,400 → 0.0% 0.0% 11,900 → 0.0% 0.0% 7,400 → 0.0% 0.0%
2022.03 2021/08/06 当初予 1,192,000 - - - 6,400 - - - 11,900 - - - 7,400 - - -
2021.03 2021/05/14 実 1,210,274 ↑ +0.0% +0.0% 4,303 ↑ +2.5% +2.5% 10,289 ↑ +0.9% +0.9% 4,989 ↑ +1.8% +1.8%
2021.03 2021/04/23 当初予 1,210,000 - - - 4,200 - - - 10,200 - - - 4,900 - - -
2020.03 2020/05/14 実 1,263,708 ↓ -0.3% +3.3% 17,590 ↑ +2.9% +17.3% 23,732 ↓ -1.1% +8.9% 16,230 ↑ +6.8% +19.3%
2020.03 2020/02/13 Q3予 1,267,000 → 0.0% +3.6% 17,100 → 0.0% +14.0% 24,000 → 0.0% +10.1% 15,200 → 0.0% +11.8%
2020.03 2019/11/07 Q2予 1,267,000 ↑ +3.6% +3.6% 17,100 ↑ +14.0% +14.0% 24,000 ↑ +10.1% +10.1% 15,200 ↑ +11.8% +11.8%
2020.03 2019/08/01 Q1予 1,223,000 → 0.0% 0.0% 15,000 → 0.0% 0.0% 21,800 → 0.0% 0.0% 13,600 → 0.0% 0.0%
2020.03 2019/05/09 当初予 1,223,000 - - - 15,000 - - - 21,800 - - - 13,600 - - -
2019.03 2019/05/09 実 1,222,199 ↑ +0.0% +2.3% 15,783 ↑ +0.5% +30.4% 21,452 ↑ +0.2% +21.2% 13,863 ↑ +0.5% +37.3%
2019.03 2019/04/24 修正予 1,222,000 ↑ +2.3% +2.3% 15,700 ↑ +29.8% +29.8% 21,400 ↑ +20.9% +20.9% 13,800 ↑ +36.6% +36.6%
2019.03 2019/02/01 Q3予 1,195,000 → 0.0% 0.0% 12,100 → 0.0% 0.0% 17,700 → 0.0% 0.0% 10,100 → 0.0% 0.0%
2019.03 2018/11/07 Q2予 1,195,000 → 0.0% 0.0% 12,100 → 0.0% 0.0% 17,700 → 0.0% 0.0% 10,100 → 0.0% 0.0%
2019.03 2018/08/01 Q1予 1,195,000 → 0.0% 0.0% 12,100 - - - 17,700 → 0.0% 0.0% 10,100 → 0.0% 0.0%
2019.03 2018/05/09 当初予 1,195,000 - - - - - - - 17,700 - - - 10,100 - - -
2018.03 2018/05/09 実 - - - - - - - - - - - - - - - -
2018.03 2018/04/27 修正予 1,213,000 ↑ +2.3% +2.3% - - - - 25,000 ↑ +33.7% +33.7% 14,300 ↑ +38.8% +38.8%
2018.03 2018/02/01 Q3予 1,186,000 → 0.0% 0.0% 14,300 → 0.0% 0.0% 18,700 → 0.0% 0.0% 10,300 → 0.0% 0.0%
2018.03 2017/11/08 Q2予 1,186,000 → 0.0% 0.0% 14,300 → 0.0% 0.0% 18,700 → 0.0% 0.0% 10,300 → 0.0% 0.0%
2018.03 2017/08/01 Q1予 1,186,000 → 0.0% 0.0% 14,300 → 0.0% 0.0% 18,700 → 0.0% 0.0% 10,300 → 0.0% 0.0%
2018.03 2017/05/11 当初予 1,186,000 - - - 14,300 - - - 18,700 - - - 10,300 - - -
2017.03 2017/05/11 実 1,231,046 ↓ -0.3% -4.2% 14,244 ↑ +5.5% -23.8% 19,844 ↑ +5.0% -17.3% 14,225 ↑ +14.7% -4.5%
2017.03 2017/02/01 Q3予 1,235,000 ↓ -3.9% -3.9% 13,500 ↓ -27.8% -27.8% 18,900 ↓ -21.3% -21.3% 12,400 ↓ -16.8% -16.8%
2017.03 2016/08/01 当初予 1,285,000 - - - 18,700 - - - 24,000 - - - 14,900 - - -
2016.03 2016/05/11 実 - - - - - - - - - - - - - - - -
2016.03 2016/04/18 修正予 1,300,000 ↑ +4.0% +8.2% 28,000 ↑ +76.1% +120.5% 34,000 ↑ +56.0% +89.9% 21,000 ↑ +81.0% +105.9%
2016.03 2016/02/01 Q3予 1,250,000 → 0.0% +4.1% 15,900 → 0.0% +25.2% 21,800 → 0.0% +21.8% 11,600 → 0.0% +13.7%
2016.03 2015/11/06 修正予 1,250,000 ↑ +4.1% +4.1% 15,900 ↑ +25.2% +25.2% 21,800 ↑ +21.8% +21.8% 11,600 ↑ +13.7% +13.7%
2016.03 2015/08/03 Q1予 1,201,000 → 0.0% 0.0% 12,700 - - - 17,900 → 0.0% 0.0% 10,200 → 0.0% 0.0%
2016.03 2015/05/12 当初予 1,201,000 - - - - - - - 17,900 - - - 10,200 - - -
2015.03 2015/05/12 実 - - - - - - - - - - - - - - - -
2015.03 2015/02/02 Q3予 1,161,000 → 0.0% -4.9% 8,900 → 0.0% -42.9% 14,500 → 0.0% -31.3% 11,700 → 0.0% -7.9%
2015.03 2014/11/06 Q2予 1,161,000 ↓ -4.9% -4.9% 8,900 ↓ -42.9% -42.9% 14,500 ↓ -31.3% -31.3% 11,700 ↓ -7.9% -7.9%
2015.03 2014/08/01 Q1予 1,221,000 → 0.0% 0.0% 15,600 → 0.0% 0.0% 21,100 → 0.0% 0.0% 12,700 → 0.0% 0.0%
2015.03 2014/05/09 当初予 1,221,000 - - - 15,600 - - - 21,100 - - - 12,700 - - -
2014.03 2014/05/09 実 1,189,627 - - - 12,328 - - - 18,303 - - - 10,407 - - -
シェア ツイート
ページトップへ戻る